Business Briefing: Tekmira to Buy Oncore and Develop Hepatitis B Drugs
Monday, January 12, 2015 - 22:20
in Mathematics & Economics
The implied market value of the merged company is about $750 million.
Updated by artificial intelligence Sat, 3 Jan 2026, 15:40:35 UTC Learn more
- Tell your friends
- Get science news via